DB Power and LPA announce strategic partnership to globally expand solutions for issuers of structured retail products

Real Time Search
CES A80 :
CES HKMI :
CES 120 :
Total Turn.

08622 HUAKANG BIOMED

Trading Add to Porfolio
Index Constituent : None
Major Shareholders Li King Yeung (27.71%)
Yu Chi Mau (24.13%)
Sector Health Care & Biotechnology
Web Site http://www.huakangbiomedical.com Tel (852) 2202-8989
Email hk@szhuakang.com Fax (852) 2202-8989
Related Equities N/A
Principal Activities The Group is principally engaged in research and development, manufacture, marketing and sales of IVD reagents and auxiliary reproductive supplies and equipment in the PRC.

Consolidated List of Substantial Shareholders

Name Number of Shares Interested % of Issued Share Capital (%) Date of Last Notice Filed (Y/M/D)
張曙光 240,000,000(L)  60.00(L)  13/12/2018
張賢陽 240,000,000(L)  60.00(L)  13/12/2018
Last Update : 2019-02-28
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool

Complete List of Directors

Director's Name Number of Shares Interested % of issued share capital (%) Date of Last Notice Filed (Y/M/D)
張曙光 240,000,000(L)  60.00(L)  13/12/2018
Last Update : 2019-02-28
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool
Back to Top